Universal cervical length screening and vaginal progesterone: Distinguishing strategy effectiveness from treatment efficacy

Mira Zethelius, Lina Bergman, Ann‐Catrin Ekelund, Cecilie Hongslo Vala, Bo Jacobsson, Pihla Kuusela, Ann Liljegren, Björn Lindkvist, Max Petzold, Petteri Sjögren, Ulla‐Britt Wennerholm, Tove Wikström · 2026

Read Universal cervical length screening and vaginal progesterone: Distinguishing strategy effectiveness from treatment efficacy by Mira Zethelius, Lina Bergman, Ann‐Catrin Ekelund, Cecilie Hongslo Vala, Bo Jacobsson, Pihla Kuusela, Ann Liljegren, Björn Lindkvist, Max Petzold, Petteri Sjögren, Ulla‐Britt Wennerholm, Tove Wikström (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13530915.txt.

Description

Mira Zethelius and co-authors reply to critics of their screening review in a 2026 letter. The review asked if checking every pregnant woman cervix length, then giving progesterone to those with a short cervix, lifts outcomes for the whole group. Critics had pressed on what the trials inside could prove.

The authors agree the two trials were built to test the strategy, not the drug worth in short cervix cases. They also grant the trials had low power, which their grade of proof marked as very low. Their claim stands narrow: the strategy value stays unsure, and bigger trials are needed before firm guidance.

Catalog record

CREATORMira Zethelius, Lina Bergman, Ann‐Catrin Ekelund, Cecilie Hongslo Vala, Bo Jacobsson, Pihla Kuusela, Ann Liljegren, Björn Lindkvist, Max Petzold, Petteri Sjögren, Ulla‐Britt Wennerholm, Tove Wikström
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE4 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13530915

Browse the full library · About the Tower of Babel